GenTrust’s Medpace MEDP Stock Holding History

GenTrust’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$352K	Sell	733 -123	-14%	-$63K	0.02%	184
2025 Q4	$481K	Buy	856 +429	+100%	+$244K	0.02%	165
2025 Q3	$220K	Buy	+427	New	+$186K	0.01%	194

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

GenTrust's MEDP Position: Q1 2026 in Review

GenTrust reduced its Medpace (MEDP) stake by 14% in Q1 2026, selling an estimated $63K and leaving 733 shares worth $352K. The position accounts for 0.02% of the portfolio, ranked #184.

GenTrust first reported a position in MEDP in Q3 2025 and has held it in 3 quarters since. The position peaked at $481K in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

GenTrust held 733 shares of Medpace worth $352K as of Q1 2026.
GenTrust sold 123 Medpace shares in Q1 2026, an estimated $63K.
Medpace made up 0.02% of GenTrust's portfolio in Q1 2026, its #184 holding.
GenTrust first reported a position in Medpace in Q3 2025 and has held it in 3 quarters since.
GenTrust's Medpace position peaked at $481K in Q4 2025.
729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on GenTrust's 13F filing for Q1 2026, filed 27 Apr 2026.